CB1 receptor modulators

Compounds of formula (I) suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention of weigh gain, treatment of diseases and cond...

Full description

Saved in:
Bibliographic Details
Main Authors NIELSEN, PETER AADAL, LINGET, JEAN-MICHEL, NOEREGAARD, PIA KARINA, BJURLING, EMELIE, HOEGBERG, THOMAS, COOPER, MARTIN, RECEVEUR, JEAN-MARIE, MURRAY, ANTHONY
Format Patent
LanguageEnglish
Published 27.06.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I) suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention of weigh gain, treatment of diseases and conditions directly or indirectly associated with obesity and overweight: wherein A
Bibliography:Application Number: AU20070336061